S

Selvita SA
WSE:SLV

Watchlist Manager
Selvita SA
WSE:SLV
Watchlist
Price: 55.5 PLN 0.91% Market Closed
Market Cap: 1B PLN
Have any thoughts about
Selvita SA?
Write Note

Selvita SA
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Selvita SA
Cost of Revenue Peer Comparison

Comparables:
I
IGN
M
MDB
R
RVU

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Selvita SA
WSE:SLV
Cost of Revenue
-zł70.1m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Cost of Revenue
-zł666k
CAGR 3-Years
51%
CAGR 5-Years
-6%
CAGR 10-Years
13%
M
Medicofarma Biotech SA
WSE:MDB
Cost of Revenue
-zł259.4k
CAGR 3-Years
55%
CAGR 5-Years
41%
CAGR 10-Years
N/A
R
Ryvu Therapeutics SA
WSE:RVU
Cost of Revenue
-zł21.3m
CAGR 3-Years
-28%
CAGR 5-Years
20%
CAGR 10-Years
-6%

See Also

What is Selvita SA's Cost of Revenue?
Cost of Revenue
-70.1m PLN

Based on the financial report for Jun 30, 2024, Selvita SA's Cost of Revenue amounts to -70.1m PLN.

What is Selvita SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
0%

Over the last year, the Cost of Revenue growth was 1%.

Back to Top